Company intelligence / Profile preview

Artiria Medical

Geneva, Switzerlandartiria-medical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Artiria Medical has developed a novel real-time deflectable guidewire for neurointerventional procedures. The device received FDA clearance and was used in first-in-human cases starting Q3 of 2023. The company secured funding to complete randomized controlled trials comparing its product to market leaders in both Europe and the US. Early results have been promising, with strong physician interest due to improved navigation, precision, and safety during stroke interventions.

Therapeutic areas: CardiovascularNeurology
Modalities: DeviceMicro-actuated deviceGuidewire technology
Industry: Surgical Medical Devices

Partnerships

Wyss Center for Bio and Neuroengineering (collaboration/partnership)

Beyond the preview

Go deeper on Artiria Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artiria Medical.

Explore the full profile